Like any test that boosts primary care revenue, this test is coming under fire.
 
Follow on Twitter  
Subscribe
Like any test that boosts primary care revenue, this test is coming under fire.
 
Follow on Twitter  
Subscribe
Previous post: UnitedHealth’s McGuire to jail?
Next post: Celebrities giving medical advice
{ 1 comment… read it below or add one }
If a internits or FP uses revenue enhancing tools…why do they always attack it. Instead, provide results of whether the test is beneficial or not. Cost effective or not. Not, just because the PCP doctor makes money off it. Where’s the evidence for or against. The article is only full of hearsay, anecdotal stories, and N of one opinions. not facts. NYT, do your readers favor and educate, not pontificate.